# TUG1: a potential endogenous reference gene for long noncoding RNA quantification in blood-based studies

**Authors:** Carlos Rodríguez-Muñoz, Anna Vila, Sally Santisteve, Anna Sánchez-Cucó, Iván D. Benítez, María C. García-Hidalgo, Marta Molinero, Manel Perez-Pons, Anna Moncusí-Moix, Ferran Barbé, Jessica González, David de Gonzalo-Calvo

PMC · DOI: 10.1186/s40364-025-00871-2 · Biomarker Research · 2025-12-30

## TL;DR

This study identifies TUG1 as a reliable reference gene for measuring long noncoding RNAs in blood samples, improving accuracy and cost-effectiveness.

## Contribution

TUG1 is shown to be the most stable endogenous control for lncRNA quantification in whole-blood studies.

## Key findings

- TUG1 consistently ranked as the most stable lncRNA across multiple algorithms in 182 individuals.
- TUG1 normalization reduced expression variability as effectively as mean-centering and better than other strategies.
- TUG1 showed minimal association with clinical variables and high consistency in external RNA-seq datasets.

## Abstract

Long noncoding RNAs (lncRNAs) are promising biomarkers, but their accurate quantification by qPCR requires stable endogenous controls. In the present study, we aimed to identify suitable reference lncRNAs for normalization in whole-blood samples. We profiled the expression of 84 lncRNAs and eight commonly used mRNA reference genes by RT-qPCR in samples from 182 individuals. Transcript stability was assessed using three widely applied algorithms: geNorm, NormFinder and BestKeeper. Twenty-nine lncRNAs met predefined expression criteria: consistent detection across all samples, a maximum quantification cycle (Cq) below 33 and a median Cq below 30. Among these, TUG1 consistently ranked as the most stable candidate across all algorithms. FGD5–AS1 and ZFAS1 were also selected based on high stability rankings. We next evaluated the effectiveness of different normalization strategies, comparing them to the gold-standard method, i.e. mean-centering. We included both the selected lncRNAs and eight commonly used mRNA reference genes. TUG1 alone achieved a reduction in expression variability comparable to mean-centering and superior to all other tested strategies, including combinations of multiple reference lncRNAs and mRNAs. Moreover, TUG1 expression showed a minimal association with clinical variables and outcomes. TUG1 was consistently identified among the lncRNAs with the highest expression levels and lowest variability across four independent external RNA-seq datasets. Our findings identify TUG1 as the most stable candidate in this cohort and suggest that it may represent a promising and cost-effective endogenous control for lncRNA quantification in whole-blood studies.

The online version contains supplementary material available at 10.1186/s40364-025-00871-2.

## Linked entities

- **Genes:** TUG1 (taurine up-regulated 1) [NCBI Gene 55000], FGD5-AS1 (FGD5 antisense RNA 1) [NCBI Gene 100505641], ZFAS1 (ZNFX1 antisense RNA 1) [NCBI Gene 441951]

## Full-text entities

- **Genes:** TUG1 (taurine up-regulated 1) [NCBI Gene 55000] {aka LINC00080, NCRNA00080, TI-227H}, FGD5-AS1 (FGD5 antisense RNA 1) [NCBI Gene 100505641], ZFAS1 (ZNFX1 antisense RNA 1) [NCBI Gene 441951] {aka C20orf199, HSUP1, HSUP2, NCRNA00275, ZNFX1-AS1}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12754918/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12754918/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12754918/full.md

---
Source: https://tomesphere.com/paper/PMC12754918